A pilot study of gemcitabine (g), oxaliplatin (o), cetuximab (c) for locally advanced or metastatic pancreatic cancer

被引：1
|
作者：
Merchan, J. R.
Venkatraman, A.
Macintyre, J.
Ciombor, K.
Levi, J.
Ribeiro, A.
Sleeman, D.
Aurea, F.
Vulfovich, M.
Rocha-Lima, C. M.
机构：
[1] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
[2] Sylvester Comprehens Canc Ctr, Miami, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.15510
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15510
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Gemcitabine and oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer
    All, M.
    Carillio, G.
    Mazzola, A.
    Bagnato, S.
    Di Leo, M. G.
    Fallica, G.
    Anna, Aiello R.
    Chiarenza, M.
    Caruso, M.
    ANNALS OF ONCOLOGY, 2006, 17 : XI52 - XI52
  • [2] Phase II Study of Gemcitabine, Oxaliplatin, and Cetuximab in Advanced Pancreatic Cancer
    Merchan, Jaime R.
    Ferrell, Annaporna
    Macintyre, Jessica
    Ciombor, Kristen K.
    Levi, Joe
    Ribeiro, Afonso
    Sleeman, Danny
    Flores, Aurea
    Lopes, Gilberto
    Rocha-Lima, Caio M.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (05): : 446 - 450
  • [3] Gemcitabine plus oxaliplatin in advanced or metastatic pretreated pancreatic cancer
    Anghel, Rodica M.
    Popescu, Irinel
    Ionescu, Mihnea
    Stanculeanu, Dana
    Minea, Laurentia
    Bacinschi, Xenia
    Cringeanu, Alexandrina
    ANNALS OF ONCOLOGY, 2006, 17 : 325 - 325
  • [4] A phase I study of cetuximab in combination with gemcitabine and radiation for locally advanced pancreatic cancer
    Chakravarthy, A. B.
    Berlin, J. D.
    Lockhart, A. C.
    Chan, E.
    Parikh, A.
    Kordowski, V.
    Reddy, R.
    Merchant, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S250 - S251
  • [5] Radiation therapy in combination with cetuximab and gemcitabine in locally advanced pancreatic cancer
    Fiore, M.
    Trodella, L.
    Valeri, S.
    Floreno, B.
    Greco, C.
    Nappo, G.
    Molfese, E.
    Trecca, P.
    Coppola, R.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S72 - S73
  • [6] Phase III study of gemcitabine [G] plus cetuximab [C] versus gemcitabine in patients [pts] with locally advanced or metastatic pancreatic adenocarcinoma [PC]: SWOG S0205 study
    Philip, P. A.
    Benedetti, J.
    Fenoglio-Preiser, C.
    Zalupski, M.
    Lenz, H.
    O'Reilly, E.
    Wong, R.
    Atkins, J.
    Abruzzese, J.
    Blanke, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study
    Gruenberger, Birgit
    Schueller, Johannes
    Heubrandtner, Ute
    Wrba, Fritz
    Tamandl, Dietmar
    Kaczirek, Klaus
    Roka, Rudolf
    Pircher, Sandra Freimann
    Gruenberger, Thomas
    LANCET ONCOLOGY, 2010, 11 (12): : 1142 - 1148
  • [8] NeoGemOx: Gemcitabine and oxaliplatin as neoadjuvant treatment for locally advanced, nonmetastasized pancreatic cancer
    Sahora, Klaus
    Kuehrer, Irene
    Eisenhut, Axel
    Akan, Belgin
    Koellblinger, Claus
    Goetzinger, Peter
    Teleky, Bela
    Jakesz, Raimund
    Peck-Radosavljevic, Markus
    Ba'ssalamah, Ahmed
    Zielinski, Christoph
    Gnant, Michael
    SURGERY, 2011, 149 (03) : 311 - 320
  • [9] Phase two clinical trial of combination oxaliplatin, irinotecan, and cetuximab for patients with locally advanced or metastatic pancreatic cancer.
    Abdou, Yara
    Friend, Sarah Cooke
    Patt, Yehuda Z.
    Gan, Christine
    Lee, Fa-Chyi
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] Clinical and pharmacokinetic study of gemcitabine (GEM) - oxaliplatin (OXA) association in metastatic or locally advanced pancreatic adenocarcinoma.
    Airoldi, M
    Cattel, L
    Passera, R
    Micari, C
    Ferrarato, E
    Zanon, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 141S - 141S
12345